The purpose of this study is to learn about the effects of a research investigational product, CT-0525, and to see if CT-0525 is safe for participants with advanced cancer. This study is the first time that CT-0525 will be given to humans. CT-0525 is a special kind of product that is made of blood cells taken from your own body. Once collected, these blood cells will be altered and infused back into your body.

Have you been diagnosed with Metastatic Castration-Resistant Prostate Cancer (mCRPC)? If so, you may be able to take part in a research study investigating if the study drug together with standard of care drug are safe and well tolerated, and whether two drugs are effective in treating prostate cancer, in comparison with standard of care alone.

The purpose of this study is to compare diet (record of the foods you eat), gut microbiome (stool sample), and cells (blood sample) in adults with IgA Nephropathy (IgAN) and compare with adults with focal segmental glomerulosclerosis (FSGS) and adults with no history of medical problems. The information we learn by doing this study may help us understand how we might be able to target the microbiome to better understand the disease process and potentially help us develop new therapies in the future.

The purpose of this research study is to test differences in food intake of items with flavored and non-flavored counterparts. The data generated will be used to select future research tasks in other studies.

This study will look at the way professors and students feel about primary source materials in the Jewish Studies undergraduate classroom. Examples of primary sources include diaries, maps, photos, and more.

Are you diagnosed with chronic graft versus host disease (cGVHD)? If so, you might be able to take part in a study to evaluate the safety and efficacy of belumosudil in combination with corticosteroids.

This study is looking at how an oral pill used in combination with insulin reduces the risk of low blood sugar.

Are you premenopausal and have been diagnosed with ER-positive, HER2-negative breast cancer and had surgery for your breast cancer? If so, you may be able to take part in a research study evaluating the addition of chemotherapy given after breast surgery with ovarian suppression and endocrine therapy versus ovarian suppression and endocrine therapy alone.

The survey and its findings will help us understand attitudes around cancer family history and genetic testing among Black people. This information will be used to develop an educational curriculum to strive towards health equity for Black people diagnosed with or at higher risk of cancer and get Black people the best cancer care.

In this pilot study, we want to find out more about the activities and health of patients after a heart attack or stent procedure.